| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1220 |
| 1 | INFLIXIMAB | 1201 |
| 2 | VEDOLIZUMAB | 601 |
| 3 | PREDNISONE | 432 |
| 4 | UPADACITINIB | 418 |
| 5 | RISANKIZUMAB-RZAA | 387 |
| 6 | USTEKINUMAB | 346 |
| 7 | AZATHIOPRINE | 206 |
| 8 | METHOTREXATE SODIUM | 195 |
| 9 | METHOTREXATE | 180 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINIDINE SULFATE TABLET | 6 | 0.0420 |
| 1 | PROCAINAMIDE HYDROCHLORIDE | 7 | 0.0283 |
| 2 | INFLIXIMAB-DYYB | 95 | 0.0276 |
| 3 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 3 | 0.0101 |
| 4 | GOLIMUMAB | 120 | 0.0095 |
| 5 | VEDOLIZUMAB | 601 | 0.0069 |
| 6 | FERRIC DERISOMALTOSE | 9 | 0.0066 |
| 7 | ACETAMINOPHEN AND ASPIRIN AND CAFFEINE | 1 | 0.0062 |
| 8 | ALOSETRON HYDROCHLORIDE | 5 | 0.0060 |
| 9 | PSYLLIUM HUSK | 8 | 0.0059 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1537 |
| 1 | Interleukin-23 Antagonist [EPC] | 740 |
| 2 | Corticosteroid [EPC] | 644 |
| 3 | Integrin Receptor Antagonist [EPC] | 643 |
| 4 | Janus Kinase Inhibitor [EPC] | 422 |
| 5 | Interleukin-12 Antagonist [EPC] | 347 |
| 6 | Purine Antimetabolite [EPC] | 207 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 190 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 182 |
| 9 | Provitamin D2 Compound [EPC] | 135 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 20 | 0.0096 |
| 2 | Integrin Receptor Antagonist [EPC] | 643 | 0.0074 |
| 3 | Interleukin-23 Antagonist [EPC] | 740 | 0.0071 |
| 4 | Macrolide Antibacterial [EPC] | 5 | 0.0049 |
| 5 | Provitamin D2 Compound [EPC] | 135 | 0.0045 |
| 6 | Interleukin-12 Antagonist [EPC] | 347 | 0.0033 |
| 7 | Janus Kinase Inhibitor [EPC] | 422 | 0.0026 |
| 8 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 9 | Adrenocorticotropic Hormone [EPC] | 2 | 0.0022 |